Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH)

被引:32
|
作者
Holland, Michael G. [1 ,2 ]
Schwope, David M. [3 ]
Stoppacher, Robert [4 ,5 ]
Gillen, Shane B. [5 ]
Huestis, Marilyn A. [3 ]
机构
[1] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY 13210 USA
[2] Upstate New York Poison Ctr, Syracuse, NY USA
[3] Natl Inst Drug Abuse, Intramural Res Program, NIH, Baltimore, MD USA
[4] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA
[5] Onondaga Cty Med Examiners Off, Syracuse, NY USA
基金
美国国家卫生研究院;
关键词
Postmortem redistribution; THC; Tetrahydrocannabinol; Cannabinoids; Cannabis; Marijuana; DRUG REDISTRIBUTION; DELTA-9-TETRAHYDROCANNABINOL THC; BLOOD CANNABINOIDS; PLASMA THC; MARIJUANA; URINE; TIME; PERFORMANCE; TOXICOLOGY; STABILITY;
D O I
10.1016/j.forsciint.2011.06.028
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Introduction: Postmortem redistribution (PMR), a well-described phenomenon in forensic toxicology for certain drugs, can result in increased central blood concentrations relative to peripheral blood concentrations. Delta(9)-tetrahydrocannabinol (THC), the primary psychoactive component in cannabis or marijuana, is the illicit substance most commonly implicated in driving under the influence of drugs (DUID) cases and fatally-injured drivers. No investigation of PMR of THC in human blood has been reported to date. Methods: Matched heart and iliac postmortem blood specimens were collected from 19 medical examiner cases (16 Males, 3 Females) with positive cannabinoid urine immunoassay screens. THC, its equipotent metabolite 11-hydroxy-THC (11-OH-THC) and non-psychoactive metabolite 11-nor-9-carboxy-THC (THCCOOH) were quantified by two-dimensional gas chromatography-mass spectrometry with cryofocusing, with 0.5 ng/mL limits of quantification (LOQ) for all analytes. Results: 10 cases had quantifiable THC and 11-OH-THC; THCCOOH was present in all 19. Median (range) heart: iliac blood ratios were 1.5 for THC (range: 0.3-3.1); 1.6 for 11-OH-THC (range: 0.3-2.7); and 1.8 for THCCOOH (range: 0.5-3.0). Discussion: Cannabinoids, in general, exhibited a mean and median central: peripheral (C:P) concentration ratio of less than 2 following death. A trend was observed for greater PMR with increasing postmortem interval between death and sampling. To our knowledge, these are the first data on THC PMR in humans, providing important scientific data to aid in the interpretation of postmortem cannabinoid concentrations in medico-legal investigations. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 50 条
  • [31] Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin and 11-nor-9-carboxy- increment 9-THC in Hair
    Hill, Virginia A.
    Schaffer, Michael, I
    Paulsen, Ryan B.
    Stowe, G. Neil
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2021, 46 (05) : 487 - 493
  • [32] On the pharmacological properties of Δ9-tetrahydrocannabinol (THC)
    Costa, Barbara
    CHEMISTRY & BIODIVERSITY, 2007, 4 (08) : 1664 - 1677
  • [33] HASHISH - SYNTHESIS OF (+/-)-2',11-DIHYDROXY-DELTA-9-TETRAHYDROCANNABINOL (THC), A METABOLITE OF DELTA-9-THC
    DUFFLEY, RP
    LAMBERT, G
    DALZELL, HC
    RAZDAN, RK
    EXPERIENTIA, 1981, 37 (09): : 931 - 932
  • [34] The Effects of Δ9-Tetrahydrocannabinol (THC) Drug History on THC Taste and Place Conditioning
    Hempel, Briana
    Wakeford, Alison
    Clasen, Matthew
    Friar, Mary
    Riley, Anthony
    FASEB JOURNAL, 2016, 30
  • [35] DEVELOPMENT AND VERIFICATION OF A LINKED THC/11-OH-THC PBPK MODEL IN HEALTHY SUBJECTS AND EXTRAPOLATION TO PREGNANCY
    Unadkat, Jashvant D.
    Patilea-Vrana, Gabriela
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S88 - S88
  • [36] DELTA(9)-TETRAHYDROCANNABINOL (DELTA(9)-THC) AND 11-OH-DELTA(9)-THC - ONSET, PATTERN AND DURATION OF BEHAVIORAL-EFFECTS AND TOLERANCE IN RATS
    FORD, RD
    BALSTER, RL
    BECKNER, JS
    FEDERATION PROCEEDINGS, 1976, 35 (03) : 644 - 644
  • [37] CATALEPSY INDUCED BY INTRASTRIATAL INJECTIONS OF DELTA-9-THC AND 11-OH-DELTA-9-THC IN RAT
    GOUGH, AL
    OLLEY, JE
    NEUROPHARMACOLOGY, 1978, 17 (02) : 137 - 144
  • [38] Kinetics of the conversion of Δ9-tetrahydrocannabinol to 11-hydroxy-Δ9-THC catalyzed by CYP2C9
    Bland, TM
    Tracy, TS
    Callery, PS
    FASEB JOURNAL, 2004, 18 (05): : A990 - A990
  • [39] Urinary excretion profiles of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol Study III.: A Δ9-THC-COOH to creatinine ratio study
    Fraser, AD
    Worth, D
    FORENSIC SCIENCE INTERNATIONAL, 2003, 137 (2-3) : 196 - 202
  • [40] BEHAVIORAL AND CARDIOVASCULAR EFFECTS OF DELTA-9-11-TETRAHYDROCANNABINOL (THC)
    MARTIN, BR
    SCIMECA, JA
    THOMAS, BR
    MARTIN, JT
    ESTRADA, U
    DEWEY, WL
    FEDERATION PROCEEDINGS, 1986, 45 (04) : 1058 - 1058